Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of CYP3A53 and CYP3A56 gene polymorphisms in Indian chronic myeloid leukemia patients.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2010

Sailaja K, Rao D Nageswara, Rao D Raghunadha, Vishnupriya S

Abstract excerpt

CYP3A5 is a member of the CYP3A gene family which metabolizes 50% of therapeutic drugs and steroid hormones. CYP3A5*3 and CYP3A5*6 polymorphisms exhibit inter-individual differences in CYP3A5 expression. The CYP3A5*3 allele (A6986G transition in intron 3) results in loss of CYP3A5 expression and the CYP3A5*6 allele (G14690A transition in exon 2, leading to the skipping of exon 7) is associated with lower CYP3A5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Cytochrome P-450 CYP3A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Polymorphism, Restriction Fragment Length

Share to Prognosis

Share to Survival Rate

Share to Young Adult

Source

Identifiers

PMID: 21039054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients.PMID 21039054Read ↗

CYP 3A5*3 Gene Polymorphism Among Sudanese Patients With Chronic Myeloid Leukemia Semantic proximity Read ↗

Polymorphism analysis of CYP3A5 in myeloid leukemiaSemantic proximity Read ↗

Association of CYP3A5*3, CYP3A4*18 & CYP2B6*6 polymorphisms with imatinib treatment outcome in Azerbaijani chronic myeloid leukaemia patients.Semantic proximity Read ↗

CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.Semantic proximity Read ↗

Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.Semantic proximity Read ↗

Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?Semantic proximity Read ↗

CYP3A4 and CYP3A5 Genes in Cyclophosphamide-treated Chronic Lymphocytic Leukemia Patients: A Pharmacogenetics Study.Semantic proximity Read ↗

[Expression of CYP3A5 mRNA in children with acute leukemia].Semantic proximity Read ↗

[Study on polymorphisms of CYP3A5 gene and their clinical role].Semantic proximity Read ↗

Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.Semantic proximity Read ↗

Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.Semantic proximity Read ↗

Phenotyping-genotyping of alternatively spliced genes in one step: study of CYP3A5*3 polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.